Understanding the aggregation propensity of TMEM106B as well as the neurodegenerative potential of TMEM106B fibrillization requires new animal and cellular models of the TMEM106B proteinopathy occurring in aging related neurodegenerative disease. This evidence concerns the gene TMEM106B and proteostasis deficiencies.